November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Tesla’s Self-Driving Narrative Is Falling Apart
Tesla Stock: The Trump Bump Is Overdone
Tesla’s Upcoming Government Double-Whammy
Nvidia’s Stock Has Huge Potential Upside For 2025
Nvidia: Still Charging Ahead
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Aridis Pharmaceuticals (ARDS) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: December 3, 2024 (15:46)
Sector: HealthcareThe share price of Aridis Pharmaceuticals, Inc. (ARDS) now
Are you interested in Aridis Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aridis Pharmaceuticals stock price in 2024, 2025, 2026. How much will one Aridis Pharmaceuticals share be worth in 2024 - 2026?
When should I take profit in Aridis Pharmaceuticals stock? When should I record a loss on Aridis Pharmaceuticals stock? What are analysts' forecasts for Aridis Pharmaceuticals stock? What is the future of Aridis Pharmaceuticals stock? We forecast Aridis Pharmaceuticals stock performance using neural networks based on historical data on Aridis Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aridis Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aridis Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Aridis Pharmaceuticals stock
The chart below shows the historical price of Aridis Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Aridis Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Aridis Pharmaceuticals, Inc. Is a biopharmaceutical company specializing in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat infections. MABs represent a treatment approach that allows the human immune system to fight infections and is designed to overcome the disadvantages associated with current therapies, such as increased drug resistance, short response times, negative effects on the human microbiome, and lack of differentiation between treatment alternatives. Its product pipeline includes human MABs that target specific pathogens associated with bacterial infections, most notably hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Its leading candidate product, AR-301, targets the alpha toxin produced by the gram-positive bacteria Staphylococcus aureus, a common pathogen associated with HAP and VAP. Its AR-101 (Aerumab) is a fully human immunoglobulin M targeting P. aeruginosa serotype O11.
Aridis Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 05 | 0.00 | 0.00 | 0.00 | 62.58 |
| Dec 06 | 0.00 | 0.00 | 0.00 | 127.62 |
| Dec 07 | 0.00 | 0.00 | 0.00 | 38.61 |
| Dec 08 | 0.00 | 0.00 | 0.00 | 125.02 |
| Dec 09 | 0.00 | 0.00 | 0.00 | 87.97 |
| Dec 10 | 0.00 | 0.00 | 0.00 | 41.01 |
| Dec 11 | 0.00 | 0.00 | 0.00 | 98.10 |
| Dec 12 | 0.00 | 0.00 | 0.00 | 80.04 |
| Dec 13 | 0.00 | 0.00 | 0.00 | 118.98 |
| Dec 14 | 0.00 | 0.00 | 0.00 | 88.45 |
| Dec 15 | 0.00 | 0.00 | 0.00 | 44.05 |
| Dec 16 | 0.00 | 0.00 | 0.00 | 112.75 |
| Dec 17 | 0.00 | 0.00 | 0.00 | 75.74 |
| Dec 18 | 0.00 | 0.00 | 0.00 | 53.36 |
| Dec 19 | 0.00 | 0.00 | 0.00 | 69.19 |
| Dec 20 | 0.00 | 0.00 | 0.00 | 41.44 |
| Dec 21 | 0.00 | 0.00 | 0.00 | 74.40 |
| Dec 22 | 0.00 | 0.00 | 0.00 | 113.05 |
| Dec 23 | 0.00 | 0.00 | 0.00 | 62.76 |
| Dec 24 | 0.00 | 0.00 | 0.00 | 100.67 |
| Dec 25 | 0.00 | 0.00 | 0.00 | 126.15 |
| Dec 26 | 0.00 | 0.00 | 0.00 | 86.74 |
| Dec 27 | 0.00 | 0.00 | 0.00 | 58.79 |
| Dec 28 | 0.00 | 0.00 | 0.00 | 43.39 |
| Dec 29 | 0.00 | 0.00 | 0.00 | 54.73 |
| Dec 30 | 0.00 | 0.00 | 0.00 | 113.09 |
| Dec 31 | 0.00 | 0.00 | 0.00 | 98.24 |
| Jan 01 | 0.00 | 0.00 | 0.00 | 44.68 |
| Jan 02 | 0.00 | 0.00 | 0.00 | 44.54 |
| Jan 03 | 0.00 | 0.00 | 0.00 | 83.06 |
Aridis Pharmaceuticals Daily Price Targets
Aridis Pharmaceuticals Stock Forecast 12-05-2024.
Forecast target price for 12-05-2024: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 38.494%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 12-06-2024.
Forecast target price for 12-06-2024: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 56.067%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 12-07-2024.
Forecast target price for 12-07-2024: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 27.853%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 12-08-2024.
Forecast target price for 12-08-2024: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 55.559%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 12-09-2024.
Forecast target price for 12-09-2024: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 46.799%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 12-10-2024.
Forecast target price for 12-10-2024: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 29.083%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
ARDS (ARDS) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 0.00 | 0.00 | 0.00 | 15.95 |
Aridis Pharmaceuticals forecast for this year
Aridis Pharmaceuticals Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $0.0000010096. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.00 | 0.00 | 0.00 | 13.42 |
| Mar | 0.00 | 0.00 | 0.00 | 16.89 |
| Mar | 0.00 | 0.00 | 0.00 | 10.94 |
| Apr | 0.00 | 0.00 | 0.00 | 17.27 |
| May | 0.00 | 0.00 | 0.00 | 10.67 |
| Jun | 0.00 | 0.00 | 0.00 | 17.03 |
| Jul | 0.00 | 0.00 | 0.00 | 15.34 |
| Aug | 0.00 | 0.00 | 0.00 | 13.56 |
| Sep | 0.00 | 0.00 | 0.00 | 13.40 |
| Oct | 0.00 | 0.00 | 0.00 | 14.86 |
| Nov | 0.00 | 0.00 | 0.00 | 11.57 |
| Dec | 0.00 | 0.00 | 0.00 | 16.87 |
Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.00 | 0.00 | 0.00 | 17.85 |
| Mar | 0.00 | 0.00 | 0.00 | 12.52 |
| Mar | 0.00 | 0.00 | 0.00 | 9.20 |
| Apr | 0.00 | 0.00 | 0.00 | 14.49 |
| May | 0.00 | 0.00 | 0.00 | 15.33 |
| Jun | 0.00 | 0.00 | 0.00 | 16.35 |
| Jul | 0.00 | 0.00 | 0.00 | 16.59 |
| Aug | 0.00 | 0.00 | 0.00 | 21.75 |
| Sep | 0.00 | 0.00 | 0.00 | 10.70 |
| Oct | 0.00 | 0.00 | 0.00 | 12.28 |
| Nov | 0.00 | 0.00 | 0.00 | 15.78 |
| Dec | 0.00 | 0.00 | 0.00 | 16.47 |
Aridis Pharmaceuticals information and performance
N/A
Market capitalization of the Aridis Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ARDS shares in the company outstanding by the market price of one share.
EBITDA of Aridis Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
